Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib in Hormone Refractory Prostate Cancer
NCT00246753Phase 2Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Oct 2005
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in prostate cancer (PCa), sponsored by UNC Lineberger Comprehensive Cancer Center. Started Oct 2005; status: completed.
02
Drugs
lapatinib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00246753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00246753.